CeriBell, Inc. (NASDAQ:CBLL – Get Free Report) traded up 3.4% during mid-day trading on Monday . The company traded as high as $21.99 and last traded at $22.0180. 84,129 shares were traded during trading, a decline of 74% from the average session volume of 317,881 shares. The stock had previously closed at $21.30.
Analyst Upgrades and Downgrades
CBLL has been the subject of several recent research reports. JPMorgan Chase & Co. reduced their price target on CeriBell from $21.00 to $17.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. TD Cowen dropped their price objective on shares of CeriBell from $36.00 to $20.00 and set a “buy” rating on the stock in a research note on Wednesday, November 5th. Canaccord Genuity Group boosted their target price on shares of CeriBell from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Wednesday, December 17th. Cowen reissued a “buy” rating on shares of CeriBell in a report on Tuesday, December 9th. Finally, Raymond James Financial assumed coverage on shares of CeriBell in a research report on Tuesday, October 21st. They set a “strong-buy” rating and a $19.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, CeriBell currently has a consensus rating of “Moderate Buy” and an average target price of $24.67.
Check Out Our Latest Research Report on CeriBell
CeriBell Trading Up 1.1%
CeriBell (NASDAQ:CBLL – Get Free Report) last released its earnings results on Tuesday, November 4th. The company reported ($0.37) EPS for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.06. The business had revenue of $22.59 million during the quarter, compared to analysts’ expectations of $21.78 million. CeriBell had a negative net margin of 63.35% and a negative return on equity of 29.63%. As a group, sell-side analysts expect that CeriBell, Inc. will post -2.46 earnings per share for the current fiscal year.
Insider Buying and Selling at CeriBell
In other news, Director William W. Burke sold 32,728 shares of the firm’s stock in a transaction that occurred on Tuesday, December 9th. The stock was sold at an average price of $22.02, for a total value of $720,670.56. Following the transaction, the director owned 17,391 shares in the company, valued at $382,949.82. This trade represents a 65.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Xingjuan Chao sold 50,000 shares of CeriBell stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $15.13, for a total value of $756,500.00. Following the completion of the sale, the chief executive officer directly owned 798,135 shares in the company, valued at $12,075,782.55. This represents a 5.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 263,156 shares of company stock valued at $4,776,822. 20.10% of the stock is owned by insiders.
Institutional Investors Weigh In On CeriBell
Hedge funds have recently modified their holdings of the business. Geode Capital Management LLC boosted its holdings in shares of CeriBell by 55.4% during the 2nd quarter. Geode Capital Management LLC now owns 447,936 shares of the company’s stock worth $8,391,000 after purchasing an additional 159,698 shares during the last quarter. Squarepoint Ops LLC purchased a new position in CeriBell during the second quarter worth approximately $1,054,000. Police & Firemen s Retirement System of New Jersey boosted its stake in CeriBell by 161.0% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 5,677 shares of the company’s stock worth $106,000 after buying an additional 3,502 shares during the last quarter. F m Investments LLC purchased a new stake in CeriBell in the 2nd quarter valued at $381,000. Finally, TimesSquare Capital Management LLC increased its stake in shares of CeriBell by 48.5% in the 2nd quarter. TimesSquare Capital Management LLC now owns 796,945 shares of the company’s stock worth $14,927,000 after acquiring an additional 260,116 shares during the last quarter.
About CeriBell
CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.
The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.
Featured Articles
- Five stocks we like better than CeriBell
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for CeriBell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CeriBell and related companies with MarketBeat.com's FREE daily email newsletter.
